Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10799753 | Biochimica et Biophysica Acta (BBA) - General Subjects | 2016 | 17 Pages |
Abstract
Many attempts to use O-glycans for biomarker, antibody and therapeutic vaccine development have been made, but suffer limitations including poor sensitivity and/or specificity that may in part derive from lack of a mechanistic understanding. Deciphering how short O-GalNAc glycans are regulated would open new perspectives to exploit this biology for therapeutic usage. This article is part of a Special Issue entitled "Glycans in personalised medicine" Guest Editor: Professor Gordan Lauc.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Joanne Chia, Germaine Goh, Frederic Bard,